Skip to main content
logo
Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
14.51
+0.01 (0.07%)
At close: Sep 18, 2026, 4:00 PM EDT
14.52
+0.01 (0.07%)
After-hours: Sep 18, 2026, 7:59 PM EDT

Ultragenyx Pharmaceutical Revenue

Ultragenyx Pharmaceutical had revenue of $214.00M in the quarter ending June 30, 2026, with 28.14% growth. This brings the company's revenue in the last twelve months to $717.21M, up 17.55% year-over-year. In the year 2025, Ultragenyx Pharmaceutical had annual revenue of $673.00M with 20.18% growth.

Revenue (ttm)
$717.21M
Revenue Growth
+17.55%
P/S Ratio
1.99
Revenue / Employee
$522,976
Employees
1,371
Market Cap
1.43B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025673.00M113.00M20.18%
Dec 31, 2024560.00M126.00M29.03%
Dec 31, 2023434.00M70.67M19.45%
Dec 31, 2022363.33M11.92M3.39%
Dec 31, 2021351.41M80.38M29.66%
Dec 31, 2020271.03M167.32M161.32%
Dec 31, 2019103.71M52.22M101.41%
Dec 31, 201851.50M48.88M1,871.48%
Dec 31, 20172.61M2.48M1,863.91%
Dec 31, 2016133.00K--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

RARE News

More News